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Abstract

Problem: The Patient Centered Medical Home (PCMH) is a model of care that improves
the quality and experience of care and decreases cost. Use of a validated depression
screening tool for adult patients is a PCMH certification requirement. The purpose of this
quality initiative was to obtain baseline data when a depression screening tool was
utilized among adult patients in an internal medicine clinic within a Midwestern public
health department.
Methods: This was a quality improvement project utilizing a descriptive and
observational design. A retrospective medical record review was used to assess the rate of
depression screening utilizing the PHQ-2 and PHQ-9, while also assessing use of
treatment or referral when indicated.
Results: A total of 941 patients (N=941) were seen and 65% (n = 607) received a PHQ-2
screening. The rate of a PHQ-9 screening after scoring  3 on the PHQ-2 was 44% (n =
42). The rate of patients treated with either medication, referral, or both was 80% (n =
93). Utilizing a Chi-Square analysis, results indicated a significant (p < .001) relationship
between PHQ-2 and PHQ-9 screenings, as well as PHQ-9 and treatment.
Implications for Practice: Most patients screened with a positive PHQ-2 were likely to
be screened positive with the PHQ-9. Likewise, those screened positive with the PHQ-9
were likely to have some treatment initiated. Patients were identified for depression who
may not otherwise have been treated. Screening adult patients with the PHQ-2 and PHQ9 depression screening tool contributed to the public health system achieving a
requirement for PCMH recognition.
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Aligning with Patient-Centered Medical Home Standards: Depression Screening in
Primary Care
Traditional primary care settings often deliver fragmented care and can be
confusing for patients and providers to navigate when multiple providers are needed
(Applequist, Miller-Day, Cronholm, Gabbay, & Bowen, 2017). Fragmented care results
in higher healthcare costs, lower quality of care, and increased rates of preventable
hospitalizations (Frandsen, Joynt, Rebitzer, & Jha, 2015). An increasingly utilized model
of care addressing these concerns is the patient-centered medical home (PCMH). The
objective of a PCMH is to provide the “triple aim” of care: improved quality of care,
decreased cost, and enhanced experience (National Committee for Quality Assurance
[NCQA], 2014). The tenets of PCMH include multi-collaborative care across all
specialties of the health care system, comprehensive care centered around the person as a
whole, efficient and effective communication approaches, utilization of appropriate
safety and quality measures, and affordable payment reform (Jackson et al., 2013; Shi et
al., 2017). Achieving PCMH recognition is a rigorous process usually taking several
years, but small changes over time have been shown to provide consistent care with
improved patient outcomes.
Depression greatly affects individuals 15-years and older and is one of the most
frequent root causes of disability in the associated population. (Siu & US Preventive
Services Task Force [USPSTF], 2016). Depression affects up to 13% of patients in the
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primary care setting, when compared to the depression prevalence of up to 9% in the US
general population (Maurer, 2012). Depression impacts not only the quality of life of
patients, but also their families (USPSTF, 2016). In the United States, depression
treatment costs reached $22.8 billion in 2009, and the cost of lost productivity was an
additional $23 billion in 2011 (USPSTF, 2016). Current recommendations from the
USPSTF (2016) reported depression screening should be occurring in the general adult
primary and specialty care settings, while also including all women receiving prenatal
and postnatal care. By properly screening these populations, accurate and appropriate
diagnosis, treatment, and follow-up can be attained (Siu & USPSTF, 2016).
The PCMH guidelines require the utilization of a validated, standardized
depression screening tool. One such tool, the Patient Health Questionnaire (PHQ)-2
screens for depression with a fairly high sensitivity (97%) and a moderate specificity
(67%) in the adult population (Maurer, 2012). This ultrashort tool has actually been
found to be as accurate as lengthier, more tedious standardized screening tools such as
the Beck Depression Inventory or Zung Depression Scale (Maurer, 2012). The PHQ-2
consists of two simple questions assessing patient anhedonia and mood over the past two
weeks (Kroenke, Spitzer, & Williams, 2003). Scores range from zero to six, with a score
of three or more requiring further evaluation with the longer PHQ-9 or by direct
interview to determine if the patient meets criteria for depression (Kroenke, Spitzer, &
Williams, 2003). The PHQ-9 is often used as a confirmation of depression when a PHQ-2
is positive (Maurer, 2012). The PHQ-9 is a validated tool, demonstrating a lower
sensitivity (61%) than the PHQ-2, but a much higher specificity (94%) for detecting
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mood disorders in adults (Maurer, 2012). A positive PHQ-2 or PHQ-9 does not always
indicate depression, thus a positive screen requires provider follow-up.
Although current recommendations suggested routine depression screenings for
primary care patients, the rate of screening has been poor. Akincigil and Mathews (2017)
examined the national rates and patterns of depression screening for patients in a primary
care setting and found only 4.2% of patients were screened for depression. Also, African
American and middle age patients were half as likely to be screened when compared to
white and elderly patients (Akincigil & Mathews, 2017).
The purpose of this quality improvement initiative was to obtain baseline data to
describe the use of depression screening tools and depression prevalence among adult
patients in an internal medicine clinic within a Midwestern public health department. The
project was to facilitate the public health department in achieving depression screening
standards necessary to align with PCMH recognition. The questions for this quality
initiative were: In patients aged 18-60 years receiving care in the internal medicine clinic
within a Midwestern public health department during a six-week timeframe:
1. What was the rate of PHQ-2 depression screenings?
2. When the PHQ-2 indicated depression risk, what was the rate of PHQ-9 screening?
3. Of those patients identified at risk for depression, what was the rate of those
who
received medication treatment and/or referral?
Review of Literature
Search engines used included Medline, EBSCO HOST, Science Direct, Cochrane,
PubMed, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL).
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The keywords used were: patient-centered medical homes, PCMH, medical homes,
depression screening tool, PHQ-2, depression, family health, internal medicine, and
primary care. Publications were selected from 2013 to 2017 except one which was
selected from an expanded search from 2007 to 2017. Inclusion criteria were limited to
adult patients, PHQ depression screenings, and PCMH. Exclusion criteria were studies
greater than 10-years old, involving only adolescent or geriatric patients, other depression
screens, and screening tools for other mental health conditions.
PCMH recognition is associated with improved patient outcomes, enriched
clinical decisions, and reduced health care costs. Sinaiko et al. (2017) performed a metaanalysis of PCMH initiatives across eight states and found the use of specialty visits
decreased by 1.5% with a total cost savings of 4.2%. Shi et al. (2017) compared all health
centers with and without PCMH who provided care to over 21 million patients. They
found there was substantial improvement in treatment for asthma, diabetes, pap
screenings, prenatal care, and tobacco cessation in health centers that were PCMH
recognized (Shi et al., 2017).
Reid et al. (2010) examined overall costs, patients’ perception of the care
experience, and burnout of providers two years after implementation of a PCMH model.
They studied before and after evaluations in a random sample of over 6,000 adults treated
in a PCMH model clinic or one of two control clinics. Reid et al. (2010) found the PCMH
model enhanced the quality of care, decreased costs, and provided a better overall
experience for both patients and providers.
Rosenthal et al. (2016) conducted a three-year study comparing differences in
patient characteristics and utilization patterns between PCMH and general primary care
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practices. The authors found a decrease in ED visits by 9.3% yielding an annual savings
of $5 million dollars (Rosenthal et al., 2016). In addition, cervical cancer screening
improved (9%), the overuse of colon cancer screenings decreased by 18.1%, and
hemoglobin A1c values decreased by 0.7% (Rosenthal et al., 2016). PCMH utilization
also demonstrated a 10.3% decrease in admission rates of patients with multiple
comorbidities and decreased the frequency of primary care visits by 1.5% (Rosenthal et
al., 2016). Hence, a PCMH allowed for less frequent but more efficient patient care visits.
Similarly, the PCMH has been shown to increase alignment with evidence-based
practice recommendations. Elder et al. (2016) conducted a retrospective chart review to
assess whether or not PCMH recognition was associated with an increased delivery of
practice recommendations for chronic pain. Higher rates of key practice
recommendations were implemented in clinics with or in the process of obtaining a
PCMH recognition (Elder et al., 2016). This was the first study to assess a PCMH effect
on chronic pain.
Nelson et al. (2017) assessed the association between elements of a PCMH and
the clinical quality in the Veterans Health Administration (VA). Results found higher
scores on each of eight components in the Progress Index and were related to improved
quality care indicators (Nelson et al., 2017). Clinics with high care coordination
performed significantly better on 33 (69%) of 48 quality measures compared to clinics
with lower care coordination (Nelson et al., 2017). Similar results were noted for access
(32 [67%]), continuity (29 [60%]), and communication (25 [52%]) (Nelson et al., 2017).
In fact, all PCMH components contributed to better performance on clinical quality
indicators. (Nelson et al., 2017).
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A gap found in the literature was the need for long-term studies related to a
PCMH and its health outcomes. Although most short-term research has shown PCMH
recognition as associated with better quality of care and decreased acute care usage,
further research is necessary to determine whether improved documentation of practice
guidelines produces sustainable and long-term improvements in patient outcomes.
Furthermore, evaluating whether populations are healthier in the long-term as a result of a
PCMH is important.
Practice guidelines for depression screening and the use of a validated screening
tool promote optimal patient outcomes and aligns with the standards to become certified
as a PCMH. Using a validated depression-screening tool can identify the need for further
assessment, but proper follow-up on a positive screen is important. Fuchs et al. (2015)
reviewed physician follow-up after a patient received a positive score on the PHQ-2
screening. They sought to determine if a PHQ-9 screening was subsequently completed
and if there were any changes in treatment. The PHQ-2 was used to screen 1,744 patients
for depression, for which over 400 (24%) screened positive (Fuchs et al., 2015).
However, only 20 (5%) of those patients received a PHQ-9 screening (Fuchs et al., 2015).
Furthermore, of the patients who tested positive on the PHQ-2 screening, 21% had initial
chief complaints of mental health concerns (Fuchs et al., 2015). Discussion of depression
was found in 39% of charts, any mental health concerns was found in 55% of charts, and
treatment options were discussed in 38% of charts. This study was limited to EHR
documentation, so if discussions occurred that weren’t documented they were not
included (Fuchs et al., 2015). In summary, the authors concluded that PHQ-2 screening
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did not substantially improve further assessment, follow-up, or alteration in treatment
related to depression (Fuchs et al., 2015).
Although routine depression screenings have the potential to identify depression
risks, they are only effective if a positive screen leads to further evaluation and changes
in care. Screening instruments can identify depression risk in adult patients, but the
finding of depression warrants evaluation and treatment to improve patient outcomes;
therefore, system changes may be required to appropriately integrate evidence-based
depression screening. Primary care settings may benefit from behavioral health referral
services in an attempt improve rates of depression screening, routine follow-up, and
proper treatment (Fuchs et al., 2015).
The Plan-Do-Study-Act (PDSA) quality improvement method is a scientific
method used to test change. The PDSA helps to provide a foundation, guide a project,
and establish boundaries for testing change. This method is well reviewed within health
care quality improvement initiatives. Taylor et al. (2013) discussed the application of the
PDSA method to improve quality in healthcare. The ‘plan’ stage of the cycle helps
identify the change that is needed and determine appropriate interventions. During the
‘plan’ stage of this project, gaps in the process are identified. Once an intervention is
planned, the cycle moves to the ‘do’ stage. During this stage, the intervention is put into
motion. During the next step of the cycle, the effects of the intervention are evaluated or
“studied”. Last, the ‘act’ step of the cycle examines any further changes necessary to
continually improve the process (Taylor et al., 2013).
Methods
Design
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This was a quality improvement project utilizing a descriptive and observational
design. A retrospective medical record review was used to assess the rate of depression
screening utilizing the PHQ-2 and PHQ-9. In addition, any treatment (including
referrals) in adult patients seen in an internal medicine primary care clinic over a sixweek period was recorded. This was the first cycle utilizing the PDSA method.
Setting
The setting was a Midwestern suburban public health department serving
approximately one million residents. There were 41,000 visits in 2016. Included within
this department were three free-standing clinics serving racially, ethnically, and
economically diverse patients throughout the county. Services included primary care in
internal medicine, women's health, pediatrics, and dental services.
Sample
A convenience sample of patients who sought care at the internal medicine clinic
from February 15-March 31, 2018 was obtained. Inclusion criteria were: patients aged
18-60 years, annual physical exam, routine follow-up, new patient, or a mental health
chief complaint. Visits for episodic care were included if the patient had not been
screened in over a year. Exclusion criteria included patients less than 18- or greater than
60-years of age, women who were pregnant or up to 6-months postpartum, and
appointments for scheduled procedures.
Approval Process
The project was approved by the public health department’s internal research
review committee (IRRC). In addition, institutional review board (IRB) approval was
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attained from the University of Missouri-St. Louis. There were no known risks or ethical
considerations related to this study.
Data Collection and Analysis
Data was collected via a retrospective medical record review. Data was collected
by the public health department’s electronic health record (EHR) specialists, who
produced bi-weekly reports. Demographic data included age, gender, race, and payor
status. In addition, the type of visit, type of depression screening, and any recommended
treatments or referrals was collected. If a PHQ-9 screening was positive for depression,
the primary investigator accessed the EHR to determine method of follow up. Data was
stored on a password-protected computer by the primary investigator. All data was deidentified and coded by using a subject ID such as A1, A2, A3, etc., for the entirety of the
data set.
Procedures
A quality improvement team was formed and included the medical director, a
public health nurse, the manager of information technology (IT) operations, and the
manager of behavioral health. The team communicated through face-face meetings,
emails, and telephone calls to discuss progress, concerns, and recommendations
throughout the process. Providers and staff were educated about PCMH and the benefits
of achieving certification, the significance of depression screening, the PHQ-2 and PHQ9 screening tools, as well as the follow-up steps including medication management,
treatment, and/or referral. Resources included adding the PHQ-9 screening tool into the
EHR, and well as adjusting the documentation process for the depression screenings. The
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EHR specialist was used as an additional resource to obtain patient data. A final meeting
occurred after completion of data analysis to discuss results and future recommendations.
Results
Summary descriptive statistics were calculated for each interval and ratio
variable. Frequencies and percentages were calculated for each nominal variable.
Between February 15 through March 31, 2018, there was a total number of approximately
941 internal medicine patient visits (N=941) that aligned with the inclusion and exclusion
criteria. Based on the number of patient visits, the most frequently observed category of
gender was Female (n = 589, 63%). The most frequently observed category of race was
Black (n = 492, 52%). The most frequently observed category of payor status was
Gateway to Better Health (n = 406, 43%). The average age of patients screened was
46.16 years (SD = 10.79) (Appendix A).
Approximately 65% (n = 607) of patients received a PHQ-2 screening. The most
frequently observed PHQ-2 score was negative, meaning a score of <3 (n = 490, 80%).
The least frequently observed PHQ-2 score was a refusal of screening by patient (n =3,
0.4%). The rate of patients who received a score of  3 on the PHQ-2 was 16% (n = 96).
The rate of patients who were given a PHQ-9 screening after scoring a  3 on the PHQ-2
was 44% (n = 42). A select number of patients with a history of depression were directly
screened with the PHQ-9, bypassing the PHQ-2 (n =18). There was an 80% rate of
patients who were treated with either medication (n =30), referral to behavioral health or
social services (n=23), or both medication and referral (n =40), following a positive
depression screening. Depression interventions were not addressed in 20% (n =23) of the
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provider notes where patients that had a positive depression screen and 7% (n =8) of
patients declined treatment.
A Chi-Square Test of independence was conducted to examine the relationship
between PHQ-2 and PHQ-9 screenings. There were four levels in the PHQ-2 variable:
Negative, Positive, Refused, and and X (which represents bypassing the PHQ-2 due to
history of depression). There were three levels in the PHQ-9 variable: Not applicable to
patient, Not done, and Received. The results of the Chi-Square test were significant, χ2(6)
= 664.18, p < .001, indicating if the PHQ-2 was positive, the PHQ-9 was likely positive
for a mental health condition such as depression. The PHQ-2 positive screening variable
and the PHQ-9 received variable had observed values that were greater than their
expected values (Appendix B).
An additional Chi-Square Test of independence was conducted to examine the
relationship between PHQ-9 screenings and recommended treatment and/or referral.
There were three levels in PHQ-9: Not applicable to patient, Not done, and Received.
There were six levels in recommended treatment and/or referral: Medication, Referral,
Medication and Referral, Declined Treatment, Not Addressed, and No treatment
indicated. The results of the Chi-Square test were significant, χ2(10) = 579.02, p < .001,
indicating a positive PHQ-9 resulted in treatment and/or referral to a mental health
specialist (Appendix C). The following level combinations had observed values that were
greater than their expected values: PHQ-9 received and Medication and Referral, PHQ-9
received and Medication, PHQ-9 received and Referral, PHQ-9 received and
interventions not addressed, PHQ-9 received and declined treatment.
Discussion
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Results in this study demonstrated the rate of PHQ-2 screenings were high using a
carefully constructed PDSA method. Almost seven out of every 10 visits were screened
with the PHQ-2 depression screening tool. While the majority of patients who received a
score of  3 on the PHQ-2 screening did not receive a reflex to the PHQ-9 screening, the
relationship between these two variables remained significant in that a positive PHQ-2 or
PHQ-9 likely indicated a mental health condition such as depression (p < .001). When
patients were positively screened for depression, the vast majority of patients (80%) were
treated with medication, referral, or both (p < .001). When patients were treated with
medication, it was found that new medication was started, medication dosages were
adjusted, or additional medications were added to current regimen. When patients were
referred to behavioral health or social services, they were referred to psychiatry, social
work services, or counseling. When a positive depression screening was not addressed,
discussion of treatment was not documented in the providers visit note. It is unknown if
depression treatment was discussed and not documented.
Based on the results of this study, the continuation of depression screenings with
the PHQ-2 and PHQ-9 standardized depression screening tools is recommended. The
PHQ-2 screening is ultrashort, easy to administer, and has shown an impressive rate of
compliance, demonstrating this to be an appropriate tool for patients with no history of
depression. When patients score a  3 on the PHQ-2, the PHQ-9 should be utilized.
Because of the increased specificity and decreased sensitivity of the PHQ-9, patients with
a history of depression should be screened with the PHQ-9, bypassing the PHQ-2.
Providers might benefit from documentation of any recommended treatment for positive
screenings. When patients decline screening and/or treatment, a recommendation would
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be to routinely document this in the provider’s visit note. Sustainability in screenings may
occur if monthly audits occur and discussion about the rates and results a part of staff
meetings.
Conclusion
The implementation of the PHQ-2 and PHQ-9 screenings were successfully
implemented when no prior standardized depression screening was routinely used.
Accessibility to the PHQ-2 and PHQ-9 in the EHR may enhance its use. The
implementation of a standardized depression screening tool assisted the public health
system to be increasingly prepared to achieve PCMH recognition. A PCMH recognition
aligns with the triple aim of improved quality of care, decreased cost, and enhanced
patient and provider experiences.
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Appendix A

Table 1
Frequency Table for Nominal Variables
Variable
Appt_Type_descr
FOLLOW-UP
NEW PATIENT
PHYSICAL
Missing
Patient_Sex
F
M
Missing
Patient_Race
AMERICAN INDIANALASKAN NATIVE
ASIAN
BLACK
OTHER RACE
WHITE
Missing
Prim_Policy_Carrier_Name
AETNA PPO
AMBETTER FROM HOME STATE HLTH
ANTHEM BLUE CROSS BLUE SHIELD
CIGNA HEALTHCARE
COVENTRY
GATEWAY TO BETTER HEALTH
HEALTHLINK CORP
HOME STATE HEALTH PLAN
MEDICAID
MEDICARE
UNINSURED
UNITED HEALTHCARE
UNITED MEDICAL RESOURCES
Missing
Note. Due to rounding errors, percentages may not equal 100%.

n

%

746
156
39
0

79.28
16.58
4.14
0.00

589
352
0

62.59
37.41
0.00

3
21
492
14
411
0

0.32
2.23
52.28
1.49
43.68
0.00

3
4
26
41
2
406
1
28
189
108
113
18
2
0

0.32
0.43
2.76
4.36
0.21
43.15
0.11
2.98
20.09
11.48
12.01
1.91
0.21
0.00
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Appendix B

Table 2
Observed and Expected Frequencies
PHQ_9
PHQ_2
Not applicable to patient
Not done
Neg
484[393.13]
5[46.82]
Pos
0[77.02]
53[9.17]
Refused
3[2.41]
0[0.29]
X
0[14.44]
0[1.72]
2
Note. χ (6) = 664.18, p < .001. Values formatted as Observed[Expected].

Received
1[50.05]
43[9.81]
0[0.31]
18[1.84]
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Appendix C

Table 3
Observed and Expected Frequencies

PHQ_9

Recommended Treatments and/or Referrals
Medication
Declined
Medication
and
Treatment
Referral

Not
applicable
0[6.42]
5[24.07]
0[36.10]
to patient
Not done
4[0.76]
11[2.87]
22[4.30]
Received
4[0.82]
14[3.06]
23[4.60]
Note. χ2(10) = 579.02, p < .001. Values formatted as Observed[Expected].

Not
Addressed
0[20.06]
10[2.39]
15[2.55]

